title: [Clinical observations concerning piracetam treatment of patients after craniocerebral injury].
abstract: Piracetam (Nootropil) is a cytoprotective to brain tissue and improving cerebral blood flow medicine. In the Department of Neurotraumatology we investigated results of piracetam treatment in a group of 100 succeeding patients admitted between 1995-96 due to craniocerebral injury. High doses (24-30 g per day) of this medicine have a positive effect on final result of treatment, when treatment is initiated immediately after the injury and described conditions are abided. We also showed usefulness of piracetam treatment in posthospital management.
authors.affiliation: Kliniki Neurotraumatologii Instytutu Neurologii Collegium Medicum Uniwersytetu Jagiellońskiego w Krakowie.
authors.forename: I
authors.initials: I
authors.lastname: Gościński
authors.forename: M
authors.initials: M
authors.lastname: Moskała
authors.forename: J
authors.initials: J
authors.lastname: Cichoński
authors.forename: J
authors.initials: J
authors.lastname: Polak
authors.forename: M
authors.initials: M
authors.lastname: Krupa
authors.forename: S
authors.initials: S
authors.lastname: Sliwonik
authors.forename: T
authors.initials: T
authors.lastname: Sondej
mesh_terms: D001930:Brain Injuries / Q000188:drug therapy*; D002560:Cerebrovascular Circulation / Q000187:drug effects; D015600:Glasgow Coma Scale; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018696:Neuroprotective Agents; D010889:Piracetam
vernacular_title: Spostrzezenia kliniczne leczenia nootropilem chorych po urazach czaszkowo-mózgowych.